GENE THERAPY’S FIRST EVER REGULATORY APPROVAL may be a door-opener for investment in this sector. For about 20+ years, proponents have hammered out solutions to delivery problems (accidentally creating DNA vaccines) and making slow but solid progress. Now it appears they are preparing for prime-time.
http://lnkd.in/FCHZgc